Manifestaciones cutáneas de la enfermedad inflamatoria intestinal / Skin manifestations of pediatric inflammatory bowel disease

La enfermedad inflamatoria intestinal (enfermedad de Crohn [EC], colitis ulcerosa, colitis indeterminada o enfermedad inflamatoria intestinal no clasificada) se acompaña de manifestaciones cutáneas hasta entre el 10 y el 15% de los casos. Hay pocos datos de prevalencia de éstas en poblaciones pediátricas, si bien algunos estudios recientes calculan que pueden estar presentes hasta en el 8% de los casos en el diagnóstico. El objetivo de este estudio es comunicar diferentes formas de manifestaciones cutáneas observadas en los pacientes pediátricos con enfermedad inflamatoria intestinal. El caso 1 se trata de un eritema nudoso de aparición al comienzo de la EC. Tiene una presentación típica en forma de nódulos eritematosos dolorosos de localización pretibial; su respuesta es buena y desaparece tras el inicio del tratamiento con infliximab. El caso 2 se trata de un caso con coexistencia de pioderma gangrenoso y síndrome de Sweet de afectación mucocutánea en un paciente con EC. La evolución de las lesiones es rápidamente progresiva y se controla con esteroides sistémicos. Se observa la presencia de importantes lesiones cicatriciales residuales. Los casos 3 y 4 se tratan de EC metastásica en glúteo y vulva, respectivamente, con buena respuesta al tratamiento con infliximab (AU)

Skin manifestations have been described in 10–15% of patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis, indeterminate colitis/inflammatory bowel disease type unclassified). There are limited data on the prevalence of these manifestations in paediatric patients, but recent studies have reported its presence in 8% of them at diagnosis. Our aim is to report the different skin manifestations observed in our paediatric patients with inflammatory bowel disease. Case 1: Erythema nodosum at Crohn's disease diagnosis. Typical presentation with painful erythematous nodules in the pretibial region and with good response to infliximab. Case 2: Coexistence of pyoderma gangrenosum and mucocutaneous Sweet's syndrome in a Crohn's disease patient. A rapidly progressive disease that was controlled with systemic steroids but with significant residual lesions. Case 3 and 4: Metastatic Crohn's disease with good response to infliximab (AU)

[Skin manifestations of pediatric inflammatory bowel disease]. / Manifestaciones cutáneas de la enfermedad inflamatoria intestinal.

Skin manifestations have been described in 10-15% of patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis, indeterminate colitis/inflammatory bowel disease type unclassified). There are limited data on the prevalence of these manifestations in paediatric patients, but recent studies have reported its presence in 8% of them at diagnosis. Our aim is to report the different skin manifestations observed in our paediatric patients with inflammatory bowel disease. Case 1: Erythema nodosum at Crohn's disease diagnosis. Typical presentation with painful erythematous nodules in the pretibial region and with good response to infliximab. Case 2: Coexistence of pyoderma gangrenosum and mucocutaneous Sweet's syndrome in a Crohn's disease patient. A rapidly progressive disease that was controlled with systemic steroids but with significant residual lesions. Case 3 and 4: Metastatic Crohn's disease with good response to infliximab.